Prognostic Value of Magnetic Resonance Imaging Defined Extent of Surgical Resection in Dogs With Intracranial

John H Rossmeisl1,2, Rell L Parker1, Richard L Shinn1

  • 1Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.

PubMed

Insights

Gross total resection (GTR) of canine intracranial meningiomas significantly improves survival and seizure control compared to subtotal resection (STR). Early post-operative MRI is crucial for assessing resection extent and guiding treatment decisions for better outcomes.

Area of Science:

  • Veterinary Neurology
  • Neurosurgery
  • Comparative Oncology

Background:

  • Intracranial meningiomas are common brain tumors in dogs.
  • Surgery is a primary treatment, but the prognostic value of resection extent is unclear.

Purpose of the Study:

  • To evaluate the prognostic impact of the extent of resection (EOR) on clinical outcomes in dogs with intracranial meningiomas.
  • To identify prognostic factors influencing survival and seizure control post-surgery.

Main Methods:

  • Retrospective study of 41 dogs undergoing surgery for intracranial meningiomas.
  • Early post-operative MRI (epoMRI) used to assess EOR (gross total resection [GTR] vs. subtotal resection [STR]).
  • Multivariable logistic regression and Kaplan-Meier analyses for prognostic factor identification and survival comparison.

Main Results:

  • GTR (59%) was associated with significantly decreased tumor progression and death rates compared to STR (41%).
  • Dogs with GTR had longer progression-free survival (PFS) and overall survival (OS) than those with STR.
  • Seizure freedom was achieved in 90% of GTR cases versus 31% of STR cases; neurological deficit improvement was similar.

Conclusions:

  • Gross total resection is a significant positive prognostic factor for canine intracranial meningiomas, improving survival and seizure control.
  • Early post-operative MRI is recommended to assess EOR and inform decisions on adjuvant therapies for subtotal resection cases.